Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR

European Cytokine Network

Volumn 14, Issue 4, 2003, Pages 211-218

  Polentarutti, Nadia ^a   Rol, Giselle Penton ^a,b   Muzio, Marta ^a,c   Bosisio, Daniela ^a,d   Camnasio, Marco ^a,e   Riva, Federica ^a,f   Zoja, Carla ^g   Benigni, Ariela ^g   Tomasoni, Susanna ^g   Vecchi, Annunciata ^a   Garlanda, Cecilia ^a   Mantovani, Alberto ^a,f  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^c PFIZER INC   (United States)

^d INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^e MOLMED S P A   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Expression; IL 1R TLRs; SIGIRR; Signal transduction regulation; TIR8

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; EPITHELIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; KIDNEY TUBULE EPITHELIUM; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALIA;

EID: 1642498347     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135.
2. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335.
3. Barton GM, Medzhitov R. 2003. Toll-like receptor signaling pathways. Science 300: 1524.
4. Sweet MJ, Leung BP, Kang D, Sogaard M, Schulz K, Trajkovic V, Campbell CC, Xu D, Liew FY. 2001. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166: 6633.
5. Brint EK, Fitzgerald KA, Smith P, Coyle AJ, Gutierrez-Ramos JC, Fallon PG, O'Neill LA. 2002. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in 1L-4 induction. J. Biol. Chem. 277: 49205.
6. Thomassen E, Renshaw BR, Sims JE. 1999. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11: 389.
7. Arend WP. 1993. Interleukin-1 receptor antagonist. Adv. Immunol. 54: 167.
8. Muzio M, Polentarutti N, Sironi M, Poli G, De Gioia L, Introna M, Mantovani A, Colotta F. 1995. Cloning and characterization of a new isoform of the interleukin-1 receptor antagonist. J. Exp. Med. 182: 623.
9. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J.G. Giri, S.K. Dower, J.E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472.
10. Colotta F, Dower SK, Sims JE, Mantovani A. 1994. The type II 'decoy' receptor: novel regulatory pathway for interleukin-1. Immunol. Today 15: 562.
11. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. 2001. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22: 328.
12. Kobayashi K, Hernandez LD, Galan JE, Janeway CA, Medzhitov JR, Flavell RA. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191.
13. Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197: 263.
14. Blasi E, Mathieson BJ, Varesio L, Cleveland JL, Borchert PA, Rapp UR. 1985. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 318: 667.
15. Dong QG, Bernasconi S, Lostaglio S, Wainstok de Calmanovici R, Martin Padura I, Breviario F, Garlanda C, Ramponi S, Mantovani A, Vecchi A. 1997. A general strategy for isolation of endothelial cells from murine tissues: characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 17: 1599.
16. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR, Martin MU, Mantovani A, Muzio M. 2002. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99: 3427.
17. Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, Mantovani A. 1998. Interleukin-10 prevents the differentation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28: 359.
18. Bianchi G, Sironi M, Ghibaudi E, Selvaggini C, Elices M, Allavena P, Mantovani A. 1993. Migration of natural killer cells across endothelial cell monolayers. J. Immunol. 151: 5135.
19. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. 2003. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102: 956.
20. Dejana E, Colella S, Conforti G, Abbadini M, Gaboli M, Marchisio PC. 1988. Fibronectin and vitronectin regulate the organization of their respective Arg-Gly-Asp adhesion receptors in cultured human endothelial cells. J. Cell. Biol. 107: 1215.
21. 2 through a PKC-dependent pathway. J. Am. Soc. Nephrol. 13: 1179.
22. Zoja C, Wang JM, Bettoni S, Sironi M, Renzi D, Chiaffarino F, Abboud HE, Van Damme J, Mantovani A, Remuzzi G, et al. 1991. Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am. J. Pathol. 138: 991.
23. Abbate M, Zoja C, Morigi M, Rottoli D, Angioletti S, Tomasoni S, Zanchi C, Longaretti L, Donadelli R, Remuzzi G. 2002. Transforming growth factor-beta 1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am. J. Pathol. 161: 2179.
24. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Mantovani A, Rothe M, Muzio M, Arditi M. 1999. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274: 7611.
25. Muzio M, Ni J, Feng P, Dixit VM. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612.
26. Saccani S, Polentarutti N, Penton-Rol G, Sims JE, Mantovani A. 1998. Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine 10: 773.
27. Penton-Rol G, Orlando S, Polentarutti N, Bernasconi S, Muzio M, Introna M, Mantovani A. 1999. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. J. Immunol. 162: 2931.
28. Jensen LE, Muzio M, Mantovani A, Whitehead AS. 2000. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J. Immunol. 164: 5277.
29. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, Li X. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4: 920-927.
30. Weshe H, Korherr C, Kracht M, Falk W, Resch K, Martin MU. 1997. The interleukin-1 receptor accessory protein (IL-IRAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272: 727.
31. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A. 1998. The human Toll signaling pathway: divergence of NK-kB and JNK/SAPK activation upstream of TRAF6. J. Exp. Med. 187: 2097.
32. O'Neill LA. 2003. SIGIRR puts the brakes on Toll-like receptors. Nat. Immunol. 4: 823.